Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Apple watches to have Glucose tracker to monitor blood sugar constantly, CEO seen testing Prototype

      Apple watches to have Glucose tracker to monitor blood sugar constantly, CEO seen testing Prototype

      Ruby Khatun Khatun21 May 2017 10:31 AM IST
      SAN FRANCISCO: Apple, the technology giant is soon going to help patients keep a continuous watch on the blood sugar levels, with their watch. The...
      Pfizer drug from Medivation deal shows promise in breast cancer: study

      Pfizer drug from Medivation deal shows promise in breast cancer: study

      Ruby Khatun Khatun21 May 2017 9:42 AM IST
      A breast cancer drug that Pfizer Inc acquired with its $14 billion purchase of Medivation showed promising anti-tumor activity following prior...
      Janssen files suit in U.S. to block sale of Samsung Bioepis Remicade copy

      Janssen files suit in U.S. to block sale of Samsung Bioepis' Remicade copy

      Ruby Khatun Khatun21 May 2017 9:40 AM IST
      SEOUL: A unit of healthcare conglomerate Johnson & Johnson filed a lawsuit to block a copy of its rheumatoid arthritis drug Remicade made by South...
      CHMP backs Novartis

      CHMP backs Novartis's Zykadia for first-line use in lung cancer

      Ruby Khatun Khatun21 May 2017 9:39 AM IST
      Novartis's push to win approval for Zykadia as an initial treatment for a type of lung cancer got a lift on Friday with a positive recommendation from...
      Response to Stent Price cap: Hospitals allegedly increasing non-stent components prices

      Response to Stent Price cap: Hospitals allegedly increasing non-stent components prices

      Ruby Khatun Khatun20 May 2017 2:42 PM IST
      The government is posed with a fresh challenge as National Pharmaceutical Pricing Authority (NPPA) has started receiving consumer complaints against...
      Indias drug pricing regulator clamps down on drug cocktails

      India's drug pricing regulator clamps down on drug cocktails

      Ruby Khatun Khatun20 May 2017 2:30 PM IST
      Mumbai: India's drug pricing regulator has demanded explanations from 65 domestic and global drugmakers for selling new forms of essential diabetes...
      USFDA Grants Bayer Priority Review for Investigational Compound Copanlisib in Follicular Lymphoma

      USFDA Grants Bayer Priority Review for Investigational Compound Copanlisib in Follicular Lymphoma

      Ruby Khatun Khatun20 May 2017 10:35 AM IST
      WHIPPANY, N.J: Bayer announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review designation for the New Drug Application...
      hCue relaunches itself with new platform myhCue

      hCue relaunches itself with new platform myhCue

      Ruby Khatun Khatun20 May 2017 10:35 AM IST
      Chennai : hCue, the most sought-after healthcare platform for doctors and pharmacies just got bigger with its new domain myhCue.com. hCue's...
      GE Healthcare’s FlexFactory to power Dr Reddy’s biosimilar expansion plans

      GE Healthcare’s FlexFactory to power Dr Reddy’s biosimilar expansion plans

      Ruby Khatun Khatun20 May 2017 10:34 AM IST
      GE Healthcare announced that Dr. Reddy’s Laboratories Limited will install India’s first-ever FlexFactory, a single-use manufacturing platform to...
      Strides Shasun inks JV pact with Vivimed Labs

      Strides Shasun inks JV pact with Vivimed Labs

      Ruby Khatun Khatun20 May 2017 10:34 AM IST
      New Delhi: Drug firm Strides Shasun said it has inked a pact with Vivimed Labs to set up two joint venture firms.The JV allows Strides to get access...
      Indian drugmakers need more time to meet International standards-Indian Pharmaceutical Association

      Indian drugmakers need more time to meet International standards-Indian Pharmaceutical Association

      Ruby Khatun Khatun19 May 2017 12:46 PM IST
      Mumbai: India's big drugmakers will need at least five more years to improve their manufacturing standards and data reliability to a level demanded by...
      Dr Reddy

      Dr Reddy's gets USFDA Approval for launching Doxorubicin Hydrochloride Liposome Injection in US

      Ruby Khatun Khatun19 May 2017 12:45 PM IST
      HYDERABAD: Dr. Reddy’s Laboratories Ltd. announced that it has received approval from the U.S. Food and Drug Administration (USFDA) to launch...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok